MYORISAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Myorisan, and when can generic versions of Myorisan launch?
Myorisan is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in MYORISAN is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Myorisan
A generic version of MYORISAN was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYORISAN?
- What are the global sales for MYORISAN?
- What is Average Wholesale Price for MYORISAN?
Summary for MYORISAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 9 |
| Patent Applications: | 7,499 |
| Drug Prices: | Drug price information for MYORISAN |
| Drug Sales Revenues: | Drug sales revenues for MYORISAN |
| DailyMed Link: | MYORISAN at DailyMed |
Recent Clinical Trials for MYORISAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| National Cancer Institute (NCI) | Phase 2 |
| National Cancer Institute (NCI) | Phase 1 |
Pharmacology for MYORISAN
| Drug Class | Retinoid |
US Patents and Regulatory Information for MYORISAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | MYORISAN | isotretinoin | CAPSULE;ORAL | 076485-001 | Jan 19, 2012 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | MYORISAN | isotretinoin | CAPSULE;ORAL | 076485-003 | Jan 19, 2012 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | MYORISAN | isotretinoin | CAPSULE;ORAL | 076485-002 | Jan 19, 2012 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | MYORISAN | isotretinoin | CAPSULE;ORAL | 076485-004 | Aug 25, 2015 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
